6505NCM163282: CLONAZEPAM TABLETS.
The CLONAZEPAM TABLETS is a the manufacturer industrial component. Key specifications include primary_container_type: BOTTLE, protective_storage_feature: SECURITY STORAGE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 100.000 TABLETS, active_medicament_medicinal_strength: 2.000 MILLIGRAMS CLONAZEPAM ACTIVE INGREDIENT, part_name_assigned_by_controlling_agency: KLONOPIN (CLONAZEPAM) 2 MG TABLET 100S. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-055-5070, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| special_features | EACH TABLET CONTAINS 2 MG OF CLONAZEPAM IN BOTTLES OF 100 TABLETS; STRENGTH: 2 MG; SCHEDULE IV CONTROLLED SUBSTANCE; STORE AT 20 TO 25 C (68 TO 77 F), (SEE USP CONTROLLED ROOM TEMPERATURE) |
| primary_container_type | BOTTLE |
| protective_storage_feature | SECURITY STORAGE |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 100.000 TABLETS |
| active_medicament_medicinal_strength | 2.000 MILLIGRAMS CLONAZEPAM ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | KLONOPIN (CLONAZEPAM) 2 MG TABLET 100S |
| NSN | 6505-01-055-5070 |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE |
| SPECIAL FEATURES | EACH TABLET CONTAINS 2 MG OF CLONAZEPAM IN BOTTLES OF 100 TABLETS; STRENGTH: 2 MG; SCHEDULE IV CONTROLLED SUBSTANCE; STORE AT 20 TO 25 C (68 TO 77 F), (SEE USP CONTROLLED ROOM TEMPERATURE) |
| PROTECTIVE STORAGE FEATURE | SECURITY STORAGE |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | KLONOPIN (CLONAZEPAM) 2 MG TABLET 100S |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 2.000 MILLIGRAMS CLONAZEPAM ACTIVE INGREDIENT |